Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of the American Society of Nephrology

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9402090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesangiolysis.

  2020cited by this paper
• The structural relationship between mesangial cells and basement membrane of the renal glomerulus

  2004cited by this paper
• Confocal microscopic and other observations on the distal end of the thick limb of the human loop of Henle

  2004cited by this paper
• Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells

  1997cited by this paper
• Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

  1997cited by this paper
• Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.

  1996cited by this paper
• Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin.

  1996cited by this paper
• Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

  1996cited by this paper
• Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

  1995cited by this paper
• Plasma cytokine levels in hemolytic uremic syndrome.

  1995cited by this paper
• Verocytotoxin-1 induces apoptosis in vero cells.

  1995cited by this paper
• The glomerular mesangium: studies of its developmental origin and markers in vivo and in vitro

  1995cited by this paper
• Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells

  1995cited by this paper
• Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells.

  1994cited by this paper
• Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages

  1994cited by this paper
• Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.

  1994cited by this paper
• Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP

  1994cited by this paper
• Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

  1994cited by this paper
• Labeled lectin studies of renal tubular dysgenesis and renal tubular atrophy of postnatal renal ischemia and end-stage kidney disease.

  1994cited by this paper
• Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.

  1993cited by this paper
• Cytokines and mesangial cells.

  1993cited by this paper
• Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content.

  1992cited by this paper
• Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

  1992cited by this paper
• Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.

  1992cited by this paper
• Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

  1992cited by this paper
• Pathology of the human mesangium in situ

  1992cited by this paper
• Explantation of mesangial cell 'hillocks': a method for obtaining human mesangial cells in culture.

  1992cited by this paper
• Toxin-induced cell lysis: protection by 3-methyladenine and cycloheximide.

  1992cited by this paper
• Susceptibility to verotoxin as a function of the cell cycle

  1992cited by this paper
• Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule

  1991cited by this paper
• Resident glomerular cells in glomerular injury: mesangial cells.

  1991cited by this paper
• Mesangial cell turnover: effect of heparin and peptide growth factors.

  1991cited by this paper
• Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

  1990cited by this paper
• Contributions of mesangial cells to glomerular immune functions

  1990cited by this paper
• Binding of the blood group‐reactive lectins to human adult kidney specimens

  1990cited by this paper
• Physiology of the mesangial cell.

  1989cited by this paper
• Direct cytotoxic action of Shiga toxin on human vascular endothelial cells

  1988cited by this paper
• The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

  1988cited by this paper
• Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

  1988cited by this paper
• Purification and characterization of verocytotoxin 2

  1988cited by this paper
• Purification and biological properties of Escherichia coli verocytotoxin

  1987cited by this paper
• The glomerular mesangial cell: an expanding role for a specialized pericyte

  1987cited by this paper
• The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.

  1987cited by this paper
• Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

  1987cited by this paper
• Coexpression of intermediate filament polypeptides in human fetal and adult tissues.

  1987cited by this paper
• Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture.

  1986cited by this paper
• Heterogeneous distribution of glycoconjugates in human kidney tubules

  1985cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

  1985cited by this paper
• Contractile properties of cultured glomerular mesangial cells.

  1985cited by this paper
• Hemolytic-Uremic Syndrome: Current Concepts and Management

  1982cited by this paper
• Lectins as fluorescence microscopic markers for saccharides in the human kidney.

  1981cited by this paper
• Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α, 6α-diphenyl glycoluril (Iodogen)

  1981cited by this paper
• An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

  1979cited by this paper
• Mesangial involvement in hemolytic-uremic syndrome. A light and electron microscopic study.

  1976cited by this paper
• Hemolytic--uremic syndrome in an adult: light and electron microscopic observations.

  1970cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper
• of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Shiga and Shiga-Like Toxins Shiga and Shiga-Like Toxins

  year unknowncited by this paper

• Mechanisms of Shiga toxin-mediated signaling and toxicity

  2020cites this paper
• Molecular Biology of Escherichia coli Shiga Toxins’ Effects on Mammalian Cells

  2020cites this paper
• Syndrome hémolytique et urémique typique de l’enfant de moins de quinze ans : devenir rénal à cinq ans et facteurs pronostiques à propos d’une série monocentrique du CHU de Lille

  2019cites this paper
• Haemolytic uraemic syndrome

  2017cites this paper
• A/E Attaching and Effacing AP-1 Activator Protein-1 BF Factor B CCP Complement Control Protein CFHR Complement Factor H Related proteins CSF-1 Colony Stimulating Factor-1 D+HUS Diarrhoea-associated Haemolytic Ura- emic Syndrome DRM Detergent Resistant Membranes EDTA Ethylenediaminetetra-acetic Acid

  2017cites this paper
• Renal Involvement in Children with HUS Hemolytic uremic syndrome (HUS)

  2015cites this paper
• Characterization of cellular pathways and potency of Shiga toxin on endothelial cells

  2015cites this paper
• Renal involvement in children with HUS

  2015cites this paper
• Comparisons of Native and Chimeric Shiga Toxins Indicate that the Binding Subunit Dictates Degree of Toxicity

  2014cites this paper
• Shiga Toxins: The Ribosome-inactivating Proteins from Pathogenic Bacteria

  2014cites this paper
• Shiga Toxin Pathogenesis: Kidney Complications and Renal Failure

  2013cites this paper
• Shiga Toxins in Human Identification of TLR4 as the Receptor That

  2013cites this paper
• Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature

  2013cites this paper
• Identification of TLR4 as the Receptor That Recognizes Shiga Toxins in Human Neutrophils

  2013cites this paper
• Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis

  2013cites this paper
• Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature

  2013cites this paper
• Shiga toxin pathogenesis: kidney complications and renal failure.

  2012cites this paper
• Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?

  2012cites this paper
• Activation of p53/ATM-dependent DNA damage signaling pathway by shiga toxin in mammalian cells.

  2012cites this paper
• Renal and neurological involvement in typical Shiga toxin-associated HUS

  2012cites this paper
• Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea.

  2010cites this paper
• Hemolytic Uremic Syndrome

  2010cites this paper
• Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease

  2010cites this paper
• Pathophysiology of typical hemolytic uremic syndrome.

  2010cites this paper
• Pathophysiology of Typical Hemolytic Uremic Syndrome

  2010cites this paper
• Risk of Pregnancy‐Related Hypertension Within 5 Years of Exposure to Drinking Water Contaminated With Escherichia coli O157:H7

  2010cites this paper
• Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction

  2010cites this paper
• Bovine epithelial cell responses to colonisation by Escherichia coli 0157:H7

  2009cites this paper
• Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water.

  2009cites this paper
• Procedural optimization of the quartz crystal microbalance for rapid detection of Escherichia coli O157:H7

  2007cites this paper
• Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells

  2006cites this paper
• Absence of renal sequelae after childhood Escherichia coli O157:H7 gastroenteritis.

  2006cites this paper
• Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.

  2006cites this paper
• Shiga toxin 'goes retro' in human primary kidney cells.

  2006cites this paper
• Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water

  2005cites this paper
• Cytolethal distending toxins: A paradigm for bacterial cyclostatins

  2005cites this paper
• Characterization of a Shiga‐Toxin 1‐Resistant Stock of Vero Cells

  2004cites this paper
• Shiga toxin-encoding phage from Escherichia coli O157:H7 : interactions with non-pathogenic E. coli and implications for toxin production.

  2004cites this paper
• Production of hemopexin by TNF-alpha stimulated human mesangial cells.

  2003cites this paper
• Interaction of Shiga toxin with endothelial cells.

  2003cites this paper
• Les cyclostatines bactériennes ou comment les bactéries manipulent le cycle cellulaire eucaryote

  2003cites this paper
• Production of hemopexin by TNF-α stimulated human mesangial cells

  2003cites this paper
• Les cyclostatines bactériennes les bactéries manipulent cellulaire

  2003cites this paper
• [Bacterial cyclostatin, or how do bacteria manipulate the eukaryotic cell cycle].

  2003cites this paper
• The medical significance of Shiga toxin-producing Escherichia coli infections. An overview.

  2003cites this paper
• Shiga toxin receptor glycolipid binding. Pathology and utility.

  2003cites this paper
• Sex steroids do not affect shigatoxin cytotoxicity on human renal tubular or glomerular cells

  2002cites this paper
• Inhibition of shiga toxin cytotoxicity in human renal cortical epithelial cells by nitrobenzylthioinosine.

  2002cites this paper
• Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.

  2002cites this paper
• Modulation of Bcl-2 Family Proteins in Primary Endothelial Cells during Apoptosis

  2002cites this paper
• Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epithelium.

  2002cites this paper
• Escherichia coli O157:H7 As An Emerging Foodborne Pathogen: A Literature Review

  2001cites this paper
• Verocytotoxin-induced apoptosis of human microvascular endothelial cells.

  2001cites this paper
• Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome

  2001cites this paper
• Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells.

  2000cites this paper
• Vascular Ultrastructure and DNA Fragmentation in Swine Infected with Shiga Toxin-Producing Escherichia coli

  2000cites this paper
• Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease.

  2000cites this paper
• Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7.

  2000cites this paper
• Facing Inward from Compartment Shores: How Many Pathways were we Looking For?

  2000cites this paper
• Ultrastructure and DNA fragmentation analysis of arterioles in swine infected with Shiga toxin-producing Escherichia coli.

  1999cites this paper
• Shiga toxins induce apoptosis in pulmonary epithelium-derived cells.

  1999cites this paper
• The pathophysiology of the hemolytic uremic syndrome.

  1999cites this paper
• Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo apoptosis.

  1999cites this paper
• Escherichia coli O157:H7 as an emerging foodborne pathogen: a literature review.

  1999cites this paper
• Mechanisms in the Pathogenesis of Enteric Diseases 2

  1999cites this paper
• Le syndrome hémolytique et urémique décrypté: cytotoxicité des vérotoxines sur les cellules endothéliales et mésangiales glomérulaires in vitro

  1998cites this paper
• Construction and screening of a combinatorial shiga toxin library

  1998cites this paper
• Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells.

  1998cites this paper
• Shiga toxin 1 elicits diverse biologic responses in mesangial cells.

  1998cites this paper
• Monocyte Chemoattractant Protein-1 and Interleukin-8 Levels in Urine and Serum of Patents with Hemolytic Uremic Syndrome

  1998cites this paper
• Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium.

  1997cites this paper